These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26682722)

  • 1. Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment.
    Suzuki J; Dodds T
    Subst Abus; 2016; 37(1):31-4. PubMed ID: 26682722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes.
    Monico LB; Gryczynski J; Mitchell SG; Schwartz RP; O'Grady KE; Jaffe JH
    J Subst Abuse Treat; 2015 Oct; 57():89-95. PubMed ID: 25986647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-step and mutual-help programs for addictive disorders.
    Chappel JN; DuPont RL
    Psychiatr Clin North Am; 1999 Jun; 22(2):425-46. PubMed ID: 10385942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.
    Mintzer IL; Eisenberg M; Terra M; MacVane C; Himmelstein DU; Woolhandler S
    Ann Fam Med; 2007; 5(2):146-50. PubMed ID: 17389539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study.
    Suzuki J; Zinser J; Klaiber B; Hannon M; Grassi H; Spinosa M; Ramirez A; Issa M; Chin Feman SP
    Subst Abus; 2015; 36(2):166-9. PubMed ID: 25738320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent substance abuse treatment clinicians' self-help meeting referral practices and adolescent attendance rates.
    Passetti LL; Godley SH
    J Psychoactive Drugs; 2008 Mar; 40(1):29-40. PubMed ID: 18472663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Text message content preferences to improve buprenorphine maintenance treatment in primary care.
    Tofighi B; Grossman E; Bereket S; D Lee J
    J Addict Dis; 2016; 35(2):92-100. PubMed ID: 26670868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined.
    Winstock AR; Nittis M; Whitton G; Lea T
    Int J Drug Policy; 2009 Jan; 20(1):85-9. PubMed ID: 18164193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.
    LaBelle CT; Han SC; Bergeron A; Samet JH
    J Subst Abuse Treat; 2016 Jan; 60():6-13. PubMed ID: 26233698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction.
    Kraus ML; Alford DP; Kotz MM; Levounis P; Mandell TW; Meyer M; Salsitz EA; Wetterau N; Wyatt SA;
    J Addict Med; 2011 Dec; 5(4):254-63. PubMed ID: 22042215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI; King VL; Brooner RK; Rastegar DA
    Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United Kingdom substance misuse treatment workers' attitudes toward 12-step self-help groups.
    Day E; Gaston RL; Furlong E; Murali V; Copello A
    J Subst Abuse Treat; 2005 Dec; 29(4):321-7. PubMed ID: 16311185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care patient characteristics associated with completion of 6-month buprenorphine treatment.
    Neumann AM; Blondell RD; Azadfard M; Nathan G; Homish GG
    Addict Behav; 2013 Nov; 38(11):2724-8. PubMed ID: 23934003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does active referral by a doctor or 12-Step peer improve 12-Step meeting attendance? Results from a pilot randomised control trial.
    Manning V; Best D; Faulkner N; Titherington E; Morinan A; Keaney F; Gossop M; Strang J
    Drug Alcohol Depend; 2012 Nov; 126(1-2):131-7. PubMed ID: 22677458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.
    Hatch-Maillette M; Wells EA; Doyle SR; Brigham GS; Daley D; DiCenzo J; Donovan D; Garrett S; Horigian VE; Jenkins L; Killeen T; Owens M; Perl HI
    J Subst Abuse Treat; 2016 Sep; 68():74-82. PubMed ID: 27431050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.
    Barry DT; Moore BA; Pantalon MV; Chawarski MC; Sullivan LE; O'Connor PG; Schottenfeld RS; Fiellin DA
    J Gen Intern Med; 2007 Feb; 22(2):242-5. PubMed ID: 17356993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.
    Kanate D; Folk D; Cirone S; Gordon J; Kirlew M; Veale T; Bocking N; Rea S; Kelly L
    Can Fam Physician; 2015 Feb; 61(2):160-5. PubMed ID: 25821874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of buprenorphine maintenance in office-based practice.
    Magura S; Lee SJ; Salsitz EA; Kolodny A; Whitley SD; Taubes T; Seewald R; Joseph H; Kayman DJ; Fong C; Marsch LA; Rosenblum A
    J Addict Dis; 2007; 26(2):13-23. PubMed ID: 17594994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs.
    Suzuki J; Ellison TV; Connery HS; Surber C; Renner JA
    Acad Psychiatry; 2016 Jun; 40(3):498-502. PubMed ID: 26017618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.